Skip to content

한국오가논 – Organon Korea logo

Main menu
    • 한국오가논
    • Our Stories
      • 비전·가치·미션
      • 다양성·형평성·포용성
    • 경영진
    • ESG
    • 기업정책
    • 핵심사업
    • 제품리스트
  • 전문의 자료
    • 보도자료
    • 공지사항
  • 인재영입
  • 여성건강 VOICE

고객문의

제품리스트

Visit Organon's LinkedIn Opens a new window Visit Organon's Instagram Opens a new window Visit Organon's YouTube Opens a new window

Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:
한국오가논 - Organon Korea » About Us » Policies & positions

기업정책

기업의 정책과 입장을 공개적이고 투명하게 공유하여 이해관계자와의 신뢰를 높입니다.

더 책임감 있게 사업을 수행하기 위해 노력합니다

여성과 환자의 혜택 제고, 공중보건 개선, 의약품 및 헬스케어 솔루션 접근성 확대 등을 위한 정책을 지원합니다. 기업의 비전과 미션을 위한 정책 개발을 도모하고, 여성과 그들 가족의 삶을 개선할 수 있도록 협력하고자 합니다.

여성의 웰빙

사회와 기업에서 양성 평등을 증진하기 위해 노력합니다. 여성의 웰빙이 향상될 때 여성의 삶 뿐만 아니라 그들 가족의 삶과 지역사회도 개선됩니다.

의료서비스 접근성

혁신적인 헬스케어 솔루션을 제공하고, 환자가 필요로 하는 의료 서비스에 접근할 수 있도록 지원함으로써 사람들이 더 나은 삶을 살 수 있도록 노력합니다.

의료혁신

혁신은 우리의 유산입니다. 환자의 혜택을 높이기 위해 의료 생태계의 혁신을 촉진하는 정책을 지원합니다.

공중보건

비전염성 질병 증가와 환경 문제와 같이 오늘날 세계의 많은 공중 보건 문제를 해결하는데 적극적인 역할을 할 것입니다.

투명성과 윤리

윤리와 정직에 대한 변함없는 실천은 우리가 누구인지를 반영하며, 이는 우리가 관련 법률 및 규제 문제들에 투명하게 참여하고 의견을 공유하는 이유입니다.

Connect with us on social

Linkedin icon Opens a new window Instagram icon Opens a new window YouTube icon Opens a new window
한국오가논 – Organon Korea logo

Company

  • 한국오가논

Resources

  • 보도자료
  • 전문의 자료

Contact us

  • 고객문의
  • 글로벌 사업장
  • Forward-Looking Statement
  • Cookie Policy
  • 개인정보처리방침
  • Term of Use
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept